125 related articles for article (PubMed ID: 26018459)
1. Cyclin-dependent kinase 5 regulates the proliferation, motility and invasiveness of lung cancer cells through its effects on cytoskeletal remodeling.
Liu JL; Gu RX; Zhou XS; Zhou FZ; Wu G
Mol Med Rep; 2015 Sep; 12(3):3979-3985. PubMed ID: 26018459
[TBL] [Abstract][Full Text] [Related]
2. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Cdk5 induces cell death of tumor-initiating cells.
Mandl MM; Zhang S; Ulrich M; Schmoeckel E; Mayr D; Vollmar AM; Liebl J
Br J Cancer; 2017 Mar; 116(7):912-922. PubMed ID: 28222068
[TBL] [Abstract][Full Text] [Related]
4. Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway.
Demelash A; Rudrabhatla P; Pant HC; Wang X; Amin ND; McWhite CD; Naizhen X; Linnoila RI
Mol Biol Cell; 2012 Aug; 23(15):2856-66. PubMed ID: 22696682
[TBL] [Abstract][Full Text] [Related]
5. Pifithrin-μ is efficacious against non-small cell lung cancer via inhibition of heat shock protein 70.
Zhou Y; Ma J; Zhang J; He L; Gong J; Long C
Oncol Rep; 2017 Jan; 37(1):313-322. PubMed ID: 28004121
[TBL] [Abstract][Full Text] [Related]
6. Cyclin-dependent kinase 5 controls vasculogenic mimicry formation in non-small cell lung cancer via the FAK-AKT signaling pathway.
Zhou X; Gu R; Han X; Wu G; Liu J
Biochem Biophys Res Commun; 2017 Oct; 492(3):447-452. PubMed ID: 28842255
[TBL] [Abstract][Full Text] [Related]
7. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells.
Strock CJ; Park JI; Nakakura EK; Bova GS; Isaacs JT; Ball DW; Nelkin BD
Cancer Res; 2006 Aug; 66(15):7509-15. PubMed ID: 16885348
[TBL] [Abstract][Full Text] [Related]
9. Cyclin-dependent kinase 5 regulates endothelial cell migration and angiogenesis.
Liebl J; Weitensteiner SB; Vereb G; Takács L; Fürst R; Vollmar AM; Zahler S
J Biol Chem; 2010 Nov; 285(46):35932-43. PubMed ID: 20826806
[TBL] [Abstract][Full Text] [Related]
10. Roscovitine regulates invasive breast cancer cell (MDA-MB231) proliferation and survival through cell cycle regulatory protein cdk5.
Goodyear S; Sharma MC
Exp Mol Pathol; 2007 Feb; 82(1):25-32. PubMed ID: 17081516
[TBL] [Abstract][Full Text] [Related]
11. Role of transcription factor FOXA1 in non‑small cell lung cancer.
Li J; Zhang S; Zhu L; Ma S
Mol Med Rep; 2018 Jan; 17(1):509-521. PubMed ID: 29115441
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of ephrin receptor A7 suppresses the proliferation and metastasis of A549 human lung cancer cells.
Li R; Sun Y; Jiang A; Wu Y; Li C; Jin M; Yan H; Jin H
Mol Med Rep; 2016 Apr; 13(4):3190-6. PubMed ID: 26936314
[TBL] [Abstract][Full Text] [Related]
13. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
14. Targeting STAT3/miR-21 axis inhibits epithelial-mesenchymal transition via regulating CDK5 in head and neck squamous cell carcinoma.
Sun SS; Zhou X; Huang YY; Kong LP; Mei M; Guo WY; Zhao MH; Ren Y; Shen Q; Zhang L
Mol Cancer; 2015 Dec; 14():213. PubMed ID: 26690371
[TBL] [Abstract][Full Text] [Related]
15. Benzo(a)pyrene promotes A549 cell migration and invasion through up-regulating Twist.
Wang Y; Zhai W; Wang H; Xia X; Zhang C
Arch Toxicol; 2015 Mar; 89(3):451-8. PubMed ID: 24847786
[TBL] [Abstract][Full Text] [Related]
16. Effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity.
Chen FF; Liu Y; Wang F; Pang XJ; Zhu CD; Xu M; Yu W; Li XJ
Cancer Gene Ther; 2015 Sep; 22(9):431-7. PubMed ID: 26384138
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of riccardin D on growth of human non-small cell lung cancer: in vitro and in vivo studies.
Xue X; Sun DF; Sun CC; Liu HP; Yue B; Zhao CR; Lou HX; Qu XJ
Lung Cancer; 2012 Jun; 76(3):300-8. PubMed ID: 22261315
[TBL] [Abstract][Full Text] [Related]
18. CDK5 Activates Hippo Signaling to Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer.
Zeng Y; Liu Q; Wang Y; Tian C; Yang Q; Zhao Y; Liu L; Wu G; Xu S
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):758-769. PubMed ID: 32407930
[TBL] [Abstract][Full Text] [Related]
19. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
20. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
Kang CG; Im E; Lee HJ; Lee EO
Bioorg Med Chem Lett; 2017 May; 27(9):1914-1918. PubMed ID: 28359791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
